SNY – Sanofi

Sanofi

SNY

$50.74

Name : Sanofi

Sector : Healthcare

Industry: Drug Manufacturers - General

Mark. Cap: $127,214,321,664.00

EPSttm : 1.85

Sanofi

$50.74

0.00%

$0.0000

Float Short %

0.17

Margin Of Safety %

Put/Call OI Ratio

0.81

EPS Next Q Diff

-1.57

EPS Last/This Y

2.11

EPS This/Next Y

0.53

Price

50.72

Target Price

Analyst Recom

1.77

Performance Q

-6.8

Relative Volume

1.03

Beta

0.54

Ticker: SNY

20 items of 1

Date	Symbol	Last	P/C OI	P/C Vol	Total OI
2024-12-19	SNY	47.53	0.71	0.64	43587
2024-12-20	SNY	47.7	0.71	0.39	43703
2024-12-23	SNY	48.41	0.78	0.67	34493
2024-12-24	SNY	48.29	0.78	0.15	34621
2024-12-26	SNY	48.45	0.78	0.43	34583
2024-12-27	SNY	48.74	0.78	2.64	34656
2024-12-30	SNY	48.24	0.79	2.21	34997
2024-12-31	SNY	48.24	0.80	1.24	35397
2025-01-02	SNY	48.18	0.80	1.51	35408
2025-01-03	SNY	48.11	0.81	2.91	35497
2025-01-06	SNY	49.22	0.83	1.10	35883
2025-01-07	SNY	49.87	0.84	0.82	36585
2025-01-08	SNY	49.22	0.84	0.79	36802
2025-01-09	SNY	49.23	0.84	0.77	36802
2025-01-10	SNY	48.74	0.85	0.91	36964
2025-01-13	SNY	48.59	0.85	0.46	37093
2025-01-14	SNY	48.46	0.85	0.02	37097
2025-01-15	SNY	49.42	0.79	0.03	38643
2025-01-16	SNY	50.72	0.80	0.10	38476
2025-01-17	SNY	50.73	0.81	0.12	38392
Date	Symbol	Last	P/C OI	P/C Vol	Total OI

20 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2024-12-19	SNY	47.53	5.8	6051.9	4.32
2024-12-20	SNY	47.71	5.8	5769.7	4.32
2024-12-23	SNY	48.39	5.8	5595.6	4.32
2024-12-24	SNY	48.29	5.8	5539.2	4.32
2024-12-26	SNY	48.43	5.8	5445.0	4.32
2024-12-27	SNY	48.74	5.8	5514.8	4.32
2024-12-30	SNY	48.23	5.8	5392.0	4.32
2024-12-31	SNY	48.25	5.8	5184.3	4.32
2025-01-02	SNY	48.17	5.8	5114.1	4.32
2025-01-03	SNY	48.15	5.8	5110.8	4.32
2025-01-06	SNY	49.22	5.8	5873.1	4.32
2025-01-07	SNY	49.86	5.8	6018.9	4.32
2025-01-08	SNY	49.23	5.8	5526.5	4.32
2025-01-09	SNY	49.23	5.8	5547.0	4.32
2025-01-10	SNY	48.75	5.8	5440.4	4.32
2025-01-13	SNY	48.58	5.8	5409.5	4.32
2025-01-14	SNY	48.47	5.8	5457.7	4.32
2025-01-15	SNY	49.37	5.8	5862.7	4.32
2025-01-16	SNY	50.74	5.8	5427.8	4.32
2025-01-17	SNY	50.72	5.8	5194.1	4.32
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2024-12-19	SNY	0	0.37	0.18
2024-12-20	SNY	0	0.37	0.18
2024-12-23	SNY	0	-0.02	0.18
2024-12-24	SNY	0	-0.02	0.18
2024-12-26	SNY	0	-0.02	0.15
2024-12-27	SNY	0	-0.02	0.15
2024-12-30	SNY	0	0.18	0.15
2024-12-31	SNY	0	0.18	0.15
2025-01-02	SNY	0	0.18	0.15
2025-01-03	SNY	0	0.18	0.15
2025-01-06	SNY	0	0.30	0.15
2025-01-07	SNY	0	0.30	0.15
2025-01-08	SNY	0	0.30	0.15
2025-01-09	SNY	0	0.30	0.15
2025-01-10	SNY	0	0.30	0.15
2025-01-13	SNY	0	0.48	0.17
2025-01-14	SNY	0	0.48	0.17
2025-01-15	SNY	0	0.48	0.17
2025-01-16	SNY	0	0.48	0.17
2025-01-17	SNY	0	0.48	0.17
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

Last Quarter Act. EPS

1.57

Avg. EPS Est. Current Quarter

0.95

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

0.48

Beta

0.54

Average Sales Estimate Current Quarter

10981

Average Sales Estimate Next Quarter

10960

Fair Value

58.41

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

-33.5

Target Price

P/E

27.97

Forward P/E

11.64

PEG

3.42

P/S

2.66

P/B

1.63

P/Free Cash Flow

21.5

EPS

1.81

Average EPS Est. Cur. Y

4.32

EPS Next Y. (Est.)

4.85

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

9.56

Relative Volume

1.03

Return on Equity vs Sector %

-16

Return on Equity vs Industry %

-23.6

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.04

EBIT Estimation

5194.1

Sanofi

Sector: Healthcare

Industry: Drug Manufacturers - General

Employees: 86088

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, Canada, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products. In addition, it offers poliomyelitis, pertussis, and hib pediatric vaccines; influenza, booster, meningitis, and travel and endemic vaccines, which includes hepatitis A, typhoid, cholera, yellow fever, and rabies vaccines. The company also provides cough, cold, and flu, allergy, and pain care products, as well as physical, mental, and digestive wellness products; and offers products for itching, hydration, aging, cracking, overnight, and specialty skincare needs like eczema. Further, it has a collaboration and license agreement with Exscientia to develop up to 15 novel small-molecule for oncology and immunology; ABL Bio, Inc. to develop ABL301, a treatment for alpha-synucleinopathies; Blackstone Life Sciences to develop pivotal studies and clinical development program; and Seagen Inc. to design, develop, and commercialize antibody-drug conjugates for cancer. Additionally, the company has a collaboration agreement with IGM Biosciences, Inc. to develop, manufacture, and commercialize IgM antibody; Skyhawk Therapeutics, Inc to discover and develop novel small molecules; and Adagene Inc., for the discovery and development of antibody-based therapies. It also has collaborations with Scribe Therapeutics Inc. to develop genome editing technologies; and co-promotion service agreement with Provention Bio, Inc. for the commercialization of teplizumab. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was incorporated in 1994 and is headquartered in Paris, France.

stock quote shares SNY – Sanofi Stock Price stock today

news today SNY – Sanofi stock forecast ,stock prediction 2023 2024 2025

marketwatch SNY – Sanofi yahoo finance google finance

stock history SNY – Sanofi invest stock market

stock prices SNY premarket after hours

ticker SNY fair value insiders trading

Investment involves risk. As a general rule, you should only trade in financial products that you are familiar with and understand the risk associated with them. The risk warning described in each financial product below is not exhaustive, you should carefully consider your investment experience, financial situation, investment objective, risk tolerance level and consult your independent financial adviser as to the suitability of your situation prior making any investment.

SNY – Sanofi

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: SNY

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Get Started

About

Last Quarter Act. EPS

Average EPS Est. Cur. Y